Global Anti-Streptolysin Reagents Market By Analysis (Qualitative, Semi-Quantitative, Quantitative), By End-User (Hospitals, Research Laboratories, Diagnostic Laboratories, Academic & Research Institutes), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2021-2031

Streptolysin is a hemolytic exotoxin generated by Streptococcaceae bacteria. Streptolysin O (SLO) and Streptolysin S (SLS) are two forms of streptomycin, with SLO being more hemolytically active than SLS due to its larger size.

To measure the quantities of antibodies generated against SLO, anti-streptolysin reagents, kits, assays, and titers are used. Anti-streptolysin reagents are used to titrate anti-streptolysin reagents with a patient’s serum sample to assess the toxicity and levels of SLO.

Acute rheumatic fever or acute post-streptococcal glomerulonephritis can be caused by infections, which can be diagnosed using anti-streptolysin reagents. To check for toxins, anti-streptolysin reagents, as well as appropriate calibrators and controls are commonly available in kits from various vendors.

Anti-streptolysin reagents provide valuable information for infection diagnosis and monitoring. Scarlet fever, tonsillitis, otitis, and erysipelas are among the illnesses that can be detected. The market for anti-streptolysin reagents is expected to increase as people become more aware of the signs and symptoms caused by antibodies produced.

Detailed Segmentation –

Analysis Type:

• Qualitative
• Semi-Quantitative
• Quantitative

End-User:

• Hospitals
• Research Laboratories
• Diagnostic Laboratories
• Academic & Research Institutes

Based on Region:

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Market Dynamics –

Driver for the Global Anti-Streptolysin Reagents Market:

The increasing availability of anti-streptolysin reagent kits over-the-counter is expected to lead to greater revenues, thereby boosting the anti-streptolysin reagents market in the process. Owing to the surging frequency of otitis and tonsillitis among youngsters, the anti-streptolysin reagents market is expected to augment gradually in years to come.

Restraints Global Anti-Streptolysin Reagents Market:

Opportunities for the Global Anti-Streptolysin Reagents Market:

Anti-streptolysin reagents are expected to be in high demand from research and academic institutes for educational purposes, creating a stable demand for anti-streptolysin reagents. Hemolysis caused by infections in post-surgical operations is also expected to lead to further expansion potential for the anti-streptolysin reagents market.

Trends for the Global Anti-Streptolysin Reagents Market:

Acute pharyngitis, one of the most prevalent infections of the throat, and its increasing prevalence across the globe is expected to aid in boosting the revenue growth trajectory of the anti-streptolysin reagents market. As more contract research & development organizations focus on understanding the efficacy and cytotoxicity of reactions, the potential for  the anti-streptolysin reagents market to subsequently grow is increase.

Competitive Landscape –

• Biosystems S.A.
• Randox Laboratories Ltd.
• Kamiya Biomedical Company
• ELITechGroup
• Erba Lachema S.R.O.
• Lab Care Diagnostics (India) Pvt. Ltd.
• Adaltis S.r.l.
• Lorne Laboratories Limited
• DiaSys Diagnostic Systems GmbH
• Diagnostic Automation/Cortez Diagnostics Inc.

For the Anti-Streptolysin Reagents Market research study, the following years have been considered to estimate the market size: